As an agonist of G-protein coupled receptor (GLP-1R), exendin-4 was confirmed beneficial to both type 2 diabetes mellitus (T2DM) and TBI (Tweedie et al., 2016). Here, GLP1R is linked to type 2 diabetes mellitus.